Prescriptions of recommended heart failure medications can be correlated with patient and physician characteristics

International Journal of Clinical Practice

Volumn 63, Issue 2, 2009, Pages 226-232

  Koschack, J ^a   Jung, H H ^a   Scherer, M ^a   Kochen, M M ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; CARDIOTONIC AGENT; PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; GENERAL PRACTICE; GERMANY; MULTICENTER STUDY; STATISTICS AND NUMERICAL DATA;

AGED; CARDIOTONIC AGENTS; CHRONIC DISEASE; FAMILY PRACTICE; FEMALE; GERMANY; HEART FAILURE; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS;

EID: 58449083267     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01937.x     Document Type: Article

References (20)

1. McMurray J, Cohen-Solal A, Dietz R et al. Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practice. Eur J Heart Fail 2001 3 : 495 502.
2. Cohen-Solal A, Desnos M, Delahaye F, Emeriau JP, Hanania G. A national survey of heart failure in French hospitals. Eur Heart J 2000 21 : 763 9.
3. Tinetti ME, Bogardus ST Jr., Agostini JV. Potential pitfalls or disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004 351 : 2870 4.
4. Rutten FH, Grobee DE, Hoes AW. Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day-practice. Eur J Heart Fail 2003 5 : 337 44.
5. Cleland JFG, Cohen-Solal A, Dietz R et al. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 2002 360 : 1631 9.
6. Nilsson G, Strender LE. Management of heart failure in primary care. A retrospective study on electronic patient records in a registered population. Scand J Prim Health Care 2002 20 : 161 5.
7. Scherer M, Sobek C, Wetzel D, Koschack J, Kochen MM. Changes in heart failure medications in patients hospitalised and discharged. BMC Fam Pract 2006 7 : 69.
8. Hach I, Maywald U, Meusel D, König JU, Kirch W. Continuity of long-term medication use after surgical hospital stay. Eur J Clin Pharmacol 2005 61 : 433 8.
9. Pont LG, van Gilst WH, Lok DJ, Kragten HJ, Haaijer-Ruskamp FM, Dutch Working Group on Heart Failure. The relevance of heart failure severity for treatment with evidence-based pharmacotherapy in general practice. Eur J Heart Fail 2003 5 : 187 93.
10. Hunt SA, Abraham WT, Chin MH et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Circulation 2005 112 : e154 235.
11. Swedberg K, Cleland JFG, Dargie H et al. Guidelines for the diagnosis and treatment of chronic heart failure (update 2005). Eur Heart J 2005 26 : 1115 40.
12. Doughty RN. Beta-blocker therapy in heart failure. Heart Fail Monit 2000 1 : 2 7.
13. Kasje WN, Denig P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM. Physician, organisational and patient characteristics explaining the use of angiotension converting enzyme inhibitors in heart failure treatment: a multilevel study. Eur J Clin Pharmacol 2005 61 : 145 51.
14. Poole-Wilson PA, Swedberg K, Cleland JFG et al. Comparison of carvedilol and metoprolol on clinical outcome in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 2003 362 : 7 13.
15. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991 325 : 293 302.
16. Muntwyler J, Cohen-Solal A, Freemantle N, Eastaugh J, Cleland JFG, Follath F. Relation of sex, age and concomitant diseases to drug prescription for heart failure in primary care in Europe. Eur J Heart Fail 2004 6 : 663 8.
17. Sturm HB, Haaijer-Ruskamp FM, Veeger NJ, Balje-Volkers CP, Swedberg K, van Gilst WH. The relevance of comorbidities for heart failure treatment in primary care: a European survey. Eur J Heart Fail 2006 8 : 31 7.
18. Albouaini K, Andron M, Alahmar A, Egred M. Beta-blocker use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions. Int J Chron Obstruct Pulmon Dis 2007 2 : 535 40.
19. Sparrow N, Adlam D, Cowley A, Hampton JR. Difficulties of introducing the National Service Framework for heart failure into general practice in the UK. Eur J Heart Fail 2003 5 : 355 61.
20. Graham RP, James PA, Cowan TM. Are clinical guidelines valid for primary care? J Clin Epidemiol 2000 53 : 949 54.